Curia expands biologics capabilities with access to Touchlight’s doggybone DNA Published: 24 July 2023 Curia collaborates with Touchlight to expand its mRNA manufacturing offering to enable access to enzymatic doggybone…
Read More
Touchlight secures government grant to support its £14m investment in scale-up DNA manufacturing Published: 29 March 2023 headline Hampton, UK, 29 March 2023 – Touchlight, a CDMO pioneering enzymatic DNA production…
Read More
Touchlight signs license agreement with Voyager for use of Touchlight’s DNA technology in Voyager’s capsid discovery platform Published: 15 November 2022 Touchlight, an innovation-driven CDMO enabling the development of genetic…
Read More
Lonza and Touchlight collaborate on end-to-end mRNA offering Published: 6 September 2022 Collaboration expands Lonza’s end-to-end offering for mRNA manufacturing with additional, differentiated source of DNA raw material, Touchlight’s doggybone…
Read More
Touchlight signs patent license agreement with Pfizer for the use of dbDNA for the manufacture of mRNA-based vaccines, therapeutics and gene therapies Published: 6 July 2022 Pfizer and Touchlight agree to patent license…
Read More
AskBio and Touchlight Restructure Joint Venture Published: 8 February 2022 Asklepios BioPharmaceutical, Inc. (AskBio), a gene therapy company wholly owned and independently operated as a subsidiary of Bayer AG, and Touchlight,…
Read More
Plasmid DNA Challenges In Advanced Therapy Manufacturing Published: 24 November 2021 Dr Tommy Duncan Introducing doggybone DNA, a synthetic antibiotic-free DNA vector. The genetic medicine revolution is underway. Just 18…
Read More
Touchlight Ranked Number Four Fastest Growing Technology Company in the UK in the 2021 Deloitte Technology Fast 50 Published: 22 November 2021 headline Touchlight, a biotechnology company pioneering enzymatic DNA…
Read More
Touchlight raises £42 million ($58 million) to meet unprecedented global DNA demand Published: 11 March 2021 Touchlight raises £42 million ($58 million) to meet unprecedented global DNA demand Completed facility…
Read More
Touchlight appoints Karen Fallen as CEO of Touchlight DNA Services Published: 15 October 2020 Former Lonza President of Biologics Manufacturing joins to continue rapid expansion of DNA contract manufacturing Touchlight’s…
Read More
